Zahraa Pharmaceuticals & Healthcare Egypt

AS A TOP PROVIDER OF ONCOLOGY SPECIALTY PRODUCTS IN EGYPT, THE MIDDLE EAST AND NORTH AFRICA ZAHRAA IS DETERMINED TO DEFINE COMMON VALUES, GOALS AND STRATEGIES TO MEET THE DEMANDS OF PATIENTS AND PHYSICIANS FIGHTING A DISEASE INCREASING BY 20% PER YEAR IN EGYPT.

EVERY YEAR, THERE ARE 100.000 NEW CANCER PATIENTS IN EGYPT!

OUR UNIQUE SELLING PROPOSITION IS PROVIDING HIGH QUALITY ONCOLOGY GENERIC PRODUCTS AT COMPETITIVE PRICES. ZAHRAA IS FOCUSED ON STEADY GROWTH IN BUILDING A STRONG PLATFORM TO SERVE THE MEDICAL MARKET AND COMPETITIVELY MEET THE CHALLENGES OF LAUNCHING NEW PRODUCTS AND EXPANDING IN THE MARKET AMONG MULTINATIONAL COMPETITORS.

WE ARE AWARE OF THE FACT THAT OUR ACTIVITIES TOUCH A GREAT NUMBER OF PEOPLE’S LIVES, AND THUS WE ARE ACUTELY CONSCIOUS OF OUR RESPONSIBILITY TO PATIENTS AND THEIR FAMILIES, AS WELL AS SOCIETY IN GENERAL.

OUR EYE IS ALWAYS ON FUTURE OPPORTUNITIES IN DEVELOPMENT AND MARKET EXPANSION. ZAHRAA'S FUTURE CHALLENGES ARE TRULY EXISTING, IN LAUNCHING NEW PRODUCTS AND OPENING NEW MARKETS AND OPPORTUNITIES FOR NEW GENERIC ONCOLOGY PRODUCTS, AS WELL AS EXPANDING OUR ACTIVITIES IN THE GULF REGION.

WE ARE DEDICATED TO PROVIDING HIGH MEDICAL VALUE TO PHYSICIANS, PATIENTS AND MEDICAL CARE ORGANIZATIONS - TO US, ZAHRAA IS NOT JUST A NAME. IT IS OUR COMMITMENT! BECAUSE HOPE MATTERS.

Download our company profile

Stragen Group

Switzerland

Simgen Pharma

Germany

OUR PARTNERS

ZAHRAA PHARMACEUTICALS & HEALTHCARE COMPANY WAS ESTABLISHED IN 1994 BY A GROUP OF PROFESSIONAL’S EXPERTISE WHO SPENT A GREAT DEAL OF TIME WORKING IN VARIOUS MULTINATIONAL PHARMACEUTICAL COMPANIES.

ZAHRAA STARTED ITS ACTIVITY AS AN AGENT FOR FOREIGN SUPPLIERS FROM JAPAN, ITALY AND OTHER COUNTRIES IN THE FIELD OF ACTIVE PHARMACEUTICAL INGREDIENTS (API'S), DISTRIBUTING AND PROMOTING API'S TO PUBLIC AND PRIVATE SECTOR PHARMACEUTICAL COMPANIES. IN 2003, ZAHRAA EXPANDED INTO TWO MAIN DIVISIONS TO MEET THE DEMANDS OF A FAST GROWING MARKET:

1ST DIVISION - FOR OUR BUSINESS IN THE API'S WITH ITS SALES FORCE MARKETING TEAM.

2ND DIVISION - THE NEWLY ESTABLISHED BRANCH FOR FINISHED DRUGS IN THE ONCOLOGY LINE, IMMUNOSUPPRESSIVE AND TRANSPLANTATION DRUGS. OUR MAIN OBJECTIVE IS LOCATING RELIABLE INTERNATIONAL SOURCES FOR FINISHED DRUGS PROVIDING HIGH MEDICAL VALUE TO PHYSICIANS, PATIENTS AND MEDICAL CARE ORGANIZATIONS, AND SECURING THESE PRODUCTS TO AID THE FIGHT AGAINST SERIOUS MEDICAL CONDITIONS IN EGYPT. IT IS OUR RESPONSIBILITY TO ASSURE ONLY THE VERY BEST QUALITY, SAFETY, WITH COMPETITIVE PRICES COMPARED TO OTHER DRUGS.

WE HAVE BEEN GRANTED THE REPRESENTATION OF A REPUTABLE INTERNATIONAL COMPANY FROM SWITZERLAND AND GERMANY, AS AN EXCLUSIVE SOLE AGENT & DISTRIBUTOR IN EGYPT FOR THEIR GENERIC ONCOLOGY PORTFOLIO.

OUR PRINCIPALS HAVE THEIR WORLDWIDE OPERATIONS, ADDING VALUE TO THEIR BUSINESS, ENSURING THE WELLBEING TO OUR CUSTOMERS (MOH BUSINESS TENDERS & RETAIL MARKET) WITH THEIR ATTRACTIVE PRICES, HIGH QUALITY & SUPPORT TO OUR COMPANY. WITH THE HELP OF OUR PARTNER ADWIA, WE ARE ABLE TO ENSURE THAT THE PRODUCTS REACH EVERY SINGLE PATIENT.